Edesa Biotech is trading at $3.94, up 5.84%, with no clear company-specific catalyst identified.
- The latest company news found predates the October 7, 2026 session.
- A Form 4 filing was reported early October 7, but the report provided no transaction details or stated connection to the share move.
- Broader markets and the supplied biotech-sector context showed declines, offering no explanation for the gain.